Australian Life Sciences Stock News

IGO Limited has appointed long-serving finance executive Ian Rowe as interim Chief Financial Officer and announced the resignation of Non-Executive Director Debra Bakker, both steps framed as part of an ongoing board and executive succession process. These leadership changes arrive as IGO contends with production challenges and expansion efforts at the Greenbushes lithium operation, highlighting how boardroom decisions intersect with key battery metals assets. We’ll now examine how the...

What triggered the latest interest in Cleanaway Waste Management? Cleanaway Waste Management (ASX:CWY) has come back into focus after strong FY25 results and a solid first half of FY26 led the company to upgrade its full-year FY26 earnings guidance. The Blueprint 2030 framework, which prioritises energy-from-waste projects, landfill gas monetisation and margin expansion, featured heavily in management commentary. A 19.6% lift in the interim fully franked dividend highlighted confidence in the...

In the past few days, Pro Medicus reported a record half-year with 28.4% revenue growth, 29.7% underlying profit before tax growth, and seven new healthcare imaging contracts worth over A$280,000,000, including a A$170,000,000 deal with the University of Colorado, while remaining debt-free with strong cash reserves. Beyond the headline results, the company’s expansion into cardiology offerings and multiple upcoming cloud-based go-lives highlights how its core imaging platform is broadening...

Scentre Group (ASX:SCG) is back in focus after management reaffirmed its 2026 guidance, highlighting record portfolio occupancy, a mixed-use redevelopment pipeline, and consistent earnings and distribution growth, even as higher interest rates keep some investors cautious. See our latest analysis for Scentre Group. Scentre Group’s recently reaffirmed guidance and redevelopment activity has played out against a share price that is up 3.23% over the past month and 11.66% over the past quarter...

Vicinity Centres has announced that long-serving independent Chairman Trevor Gerber will retire from the Board at the 2026 AGM, with experienced director Patrick Allaway appointed as Non-executive Director and Chairman-elect from 15 June 2026, subject to securityholder approval. This planned leadership handover marks a shift after Mr Gerber’s role in reshaping Vicinity’s portfolio toward premium, fortress-style retail assets and steering the group through the COVID-19 period. We’ll now...

In recent months, PLS Group Limited has approved about A$175.0 million of early P2000 works while facing higher projected capital costs of roughly A$1.8 billion and increased scrutiny of execution risk across its Pilgangoora expansion plans. At the same time, the company’s fortunes have been closely tied to volatile lithium prices and sentiment swings, with analyst views split between caution over cost inflation and optimism about its scale and downstream partnerships. We’ll now examine how...

Record results and upgraded guidance put NRW Holdings in focus NRW Holdings (ASX:NWH) is back on investor radars after reporting record first half FY2026 results, lifting full year revenue guidance and highlighting the contribution from its recent Fredon Industries acquisition. See our latest analysis for NRW Holdings. The record FY2026 half year and upgraded guidance arrive after a strong run for NRW Holdings, with the 90 day share price return of 26.74% and year to date share price return...

Why this BWP Trust distribution update matters for income investors BWP Trust (ASX:BWP) has attracted attention after the boards of BWP Management and BWP Property Group released a preliminary half year distribution estimate of 9.83 cents per stapled security, 4.0% above the prior period. The distribution is expected to be paid entirely from BWP Trust, with no dividend from BWP Property Group Ltd for this period. Key dates around the ex-distribution, record date and payment schedule are now...

Medibank Private (ASX:MPL) is back in focus after robust premium revenue growth and steady operating margins during an inflationary period, which coincided with increased institutional interest and bullish technical signals on the stock chart. See our latest analysis for Medibank Private. At a recent share price of A$4.90, Medibank Private has seen a 9.38% 90 day share price return and a 61.35% three year total shareholder return. This suggests that momentum has been building over time rather...

Genesis Minerals has reported past record annual gold production of 214,311 ounces in FY2025 and confirmed it remains on track to meet its FY2026 guidance of 260,000 to 290,000 ounces, backed by a debt-free balance sheet and more than A$600,000,000 in cash. This combination of higher output and financial flexibility gives the company greater capacity to fund exploration, progress projects like Tower Hill and Laverton, and potentially smooth operational risk. We’ll now examine how Genesis...

MFF Capital Investments recently outlined its intention to lift its FY26 dividend per share by 23%, extending a pattern of annual dividend increases that has been in place since 2018. This reinforces the company’s emphasis on using a diversified portfolio of high-quality global businesses to support a progressively growing stream of shareholder distributions. Against this backdrop, we’ll examine how the planned dividend increase shapes MFF Capital Investments’ investment narrative around...

With Kevin Warsh signaling that interest rates could still rise while inflation sits above 4% and rate cuts stay on hold, many investors are rethinking how they get paid to wait in the stock market. High valuations in the S&P 500 and heavy reliance on tech stocks can make reliable cash flows and dividends look more attractive as a stabilizer. This article looks at three dividend stocks that appear well positioned within our screener’s criteria in light of these macro signals. It also explains...

Artificial intelligence in healthcare is drawing fresh attention as global growth signals look mixed, rates stay in focus, and hospitals and drug developers search for ways to do more with limited resources. While manufacturing and services data point to patchy momentum across regions, AI healthcare stocks sit at the intersection of cost pressure, demand for better diagnostics, and the push toward remote care and automation. This article highlights three stocks from the Transformative AI...

As the Australian market braces for the latest CPI data release, investors are keeping a close eye on potential impacts from inflation and interest rate changes, with the ASX 200 showing modest gains in futures trading. In this context, penny stocks—though an outdated term—remain relevant as they highlight smaller or less-established companies that can offer significant value. By focusing on those with strong financials and growth potential, investors may uncover promising opportunities among...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

REA Group (ASX:REA) is under pressure after broker downgrades coincided with federal budget property tax proposals that target investors. This has raised concerns about weaker housing turnover, fewer listings and the impact of an early A$200 million buyback completion. See our latest analysis for REA Group. At A$131.52, REA Group’s share price has retreated sharply, with a 1-month share price return down 13.49% and a 1-year total shareholder return down 43.12%, signalling fading momentum as...

Cosmos Exploration subsidiary EAU Lithium has issued a formal Election Notice to acquire Vulcan Energy Resources’ Adsorption‑type Direct Lithium Extraction (A‑DLE) PP4 pilot plant in Germany, following acceptance testing of the unit that has been central to Vulcan’s technology development. The move positions Vulcan’s A‑DLE and VULSORB technologies within an emerging Bolivian project alongside state-owned Yacimientos de Litio Bolivianos, underscoring growing third-party interest in Vulcan’s...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

ALS Ltd was added to the S&P/ASX 50 index before the Australian market opened on Monday, replacing Pro Medicus and coinciding with its dividend reinvestment plan and FY2027 outlook for mid-to-high single-digit organic revenue growth. This index inclusion highlights how ALS’s scale and expectations for continued business expansion are drawing fresh interest, even as environmental demand and foreign exchange remain key operational risks. We’ll now explore how ALS’s inclusion in the S&P/ASX 50...

Iluka Resources has in recent days secured its first rare earths offtake agreement for its Eneabba refinery with a global automotive company, locking in at least US$155 million in take-or-pay revenue and incorporating protections against extreme price swings as construction of the Western Australian facility advances. This agreement not only underpins Eneabba’s economics but also reinforces Iluka’s role in building Australia’s onshore critical minerals processing capacity and reducing...

South32 (ASX:S32) has been back in focus after reporting H1 FY2026 results with higher underlying earnings and profit, while progressing its Hermosa critical minerals project and addressing rail constraints at its South Africa Manganese operations. See our latest analysis for South32. At a recent share price of A$4.14, South32’s 7 day share price return is down 3.0% and the 30 day share price return is down 4.8%. However, the year to date share price return of 16.6% and 1 year total...

Why the CMB.TECH shipping deal matters for Fortescue stock Fortescue (ASX:FMG) has drawn investor attention after agreeing with CMB.TECH NV to charter up to 12 ammonia-capable Newcastlemax vessels, aimed at lowering shipping emissions and supporting ammonia fuel adoption. See our latest analysis for Fortescue. Despite the CMB.TECH agreement highlighting Fortescue’s push into lower carbon shipping, recent momentum has softened, with the share price down 10.37% over the past month and 12.96%...

On June 15, 2026, Perseus Mining announced it had increased its equity buyback authorization by A$50 million to A$150 million in total. This larger buyback program highlights management’s willingness to commit additional capital to repurchasing shares, which can influence how investors view capital allocation discipline. Next, we’ll examine how this expanded A$150 million buyback authorization may reshape Perseus Mining’s existing investment narrative and risk-reward profile. Rare earth...

Region Group (ASX:RGN) has declared an ordinary unfranked dividend of A$0.072 per stapled security for the six months ending 30 June 2026, highlighting its current income profile for investors. See our latest analysis for Region Group. The upcoming A$0.072 distribution comes as Region Group’s recent share price performance has been steady, with a 30 day share price return of 6.14% and a 1 year total shareholder return of 11.24%. Meanwhile, the 3 year and 5 year total shareholder returns of...